High-density lipoprotein function - Recent advances

被引:220
作者
Ansell, BJ [1 ]
Watson, KE [1 ]
Fogelman, AM [1 ]
Navab, M [1 ]
Fonarow, GC [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Atherosclerosis Res Unit,Div Cardiol, Los Angeles, CA USA
关键词
D O I
10.1016/j.jacc.2005.06.080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although high-density lipoproteins (HDL) possess many features that contribute to the association between elevated HDL cholesterol and protection from atherosclerosis, these lipoproteins may be modified in certain individuals and/or circumstances to become proinflammatory. The ability of HDL to inhibit or paradoxically to enhance vascular inflammation, lipid oxidation, plaque growth, and thrombosis reflects changes in specific enzyme and protein components. The anti-inflammatory and proinflammatory functional properties of HDL can now be assessed using cell-based and cell-free assays. Acute or chronic systemic inflammation and the metabolic syndrome appear to render HDL proinflammatory. In contrast, statins and experimental agents such as apolipoprotein A-1 mimetics render HDL more anti-inflammatory. Functional characterization of HDL is a promising method for enhanced assessment of cardiovascular risk and effectiveness of risk reduction.
引用
收藏
页码:1792 / 1798
页数:7
相关论文
共 54 条
  • [1] Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL
    Angelin, B
    Parini, P
    Eriksson, M
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2002, 3 (04) : 23 - 30
  • [2] Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
    Ansell, BJ
    Navab, M
    Hama, S
    Kamranpour, N
    Fonarow, G
    Hough, G
    Rahmani, S
    Mottahedeh, R
    Dave, R
    Reddy, ST
    Fogelman, AM
    [J]. CIRCULATION, 2003, 108 (22) : 2751 - 2756
  • [3] REGRESSION OF ATHEROSCLEROTIC LESIONS BY HIGH-DENSITY-LIPOPROTEIN PLASMA FRACTION IN THE CHOLESTEROL-FED RABBIT
    BADIMON, JJ
    BADIMON, L
    FUSTER, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) : 1234 - 1241
  • [4] The inflammation: Lipoprotein cycle
    Barter, P
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (02) : 15 - 20
  • [5] The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport
    Bergt, C
    Pennathur, S
    Fu, XY
    Byun, J
    O'Brien, K
    McDonald, TO
    Singh, P
    Anantharamaiah, GM
    Chait, A
    Brunzell, J
    Geary, RL
    Oram, JF
    Heinecke, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) : 13032 - 13037
  • [6] Increasing HDL cholesterol levels
    Brewer, HB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) : 1491 - 1494
  • [7] High-density lipoproteins: A new potential therapeutic target for the prevention of cardiovascular disease
    Brewer, HB
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) : 387 - 391
  • [8] Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol
    Brousseau, ME
    Schaefer, EJ
    Wolfe, ML
    Bloedon, LT
    Digenio, AG
    Clark, RW
    Mancuso, JP
    Rader, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) : 1505 - 1515
  • [9] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
    Brown, BG
    Zhao, XQ
    Chait, A
    Fisher, LD
    Cheung, MC
    Morse, JS
    Dowdy, AA
    Marino, EK
    Bolson, EL
    Alaupovic, P
    Frohlich, J
    Albers, JJ
    Serafini, L
    Huss-Frechette, E
    Wang, S
    DeAngelis, D
    Dodek, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) : 1583 - 1592
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497